Home › Funds › JOHNSON & JOHNSON › PRCT

JOHNSON & JOHNSON position in PRCT

PROCEPT BIOROBOTICS CORP · Health Care

JOHNSON & JOHNSON reported holding 357,939 shares of PRCT (PROCEPT BIOROBOTICS CORP) in its Q3 2026 13F filing — a position valued at US$6.5M, representing 0.86% of its reported portfolio and ranking #11 among its reported holdings. JOHNSON & JOHNSON has disclosed PRCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)357.94K sh
Reported value held$6.52M
Portfolio Weight0.86%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How JOHNSON & JOHNSON's PRCT position evolved

JOHNSON & JOHNSON first disclosed a stake in PRCT in Q3 2023 at 357,939 shares (US$11.7M). The position peaked in Q4 2024 at 357,939 shares, worth US$28.8M. Across 13 filings, JOHNSON & JOHNSON held the position steady without any share-count change. The most recent filing (Q3 2026) shows 357,939 shares valued at US$6.5M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 357.94K $11.74M New
Q4 2023 357.94K $15.00M Hold
Q1 2024 357.94K $17.69M Hold
Q2 2024 357.94K $21.87M Hold
Q3 2024 357.94K $28.68M Hold
Q4 2024 357.94K $28.82M Hold
Q1 2025 357.94K $20.85M Hold
Q2 2025 357.94K $20.37M Hold
Q3 2025 357.94K $12.77M Hold
Q4 2025 357.94K $11.26M Hold
Q1 2026 357.94K $8.95M Hold
Q2 2026 357.94K $8.08M Hold
Q3 2026 357.94K $6.52M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRCT and 13F data

PRCT (PROCEPT BIOROBOTICS CORP) is a Health Care company. 17 other funds we track also report a position in PRCT — the largest reported positions include Soleus Capital Management, L.P. (US$22.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRCT

All PRCT fund holders →

FAQ

How long has JOHNSON & JOHNSON held PRCT?

JOHNSON & JOHNSON has disclosed PRCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is JOHNSON & JOHNSON's current position in PRCT?

As of Q3 2026, JOHNSON & JOHNSON holds 357.94K shares of PRCT (PROCEPT BIOROBOTICS CORP), valued at $6.52M, representing 0.86% of its reported portfolio and ranking #11.

Has JOHNSON & JOHNSON been buying or selling PRCT?

In the latest 13F filing (Q3 2026), JOHNSON & JOHNSON held unchanged its position in PRCT. The position peaked in Q4 2024 at 357.94K shares.

Which other funds hold PRCT?

Other major institutional holders of PRCT include Soleus Capital Management, L.P., among 17 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.